Search - tctmd.com

Displaying 61 - 80 of 83

Sort: Relevancy | Date

Presentation NY Valves 2025

Case #2: A Patient With Symptomatic Torrential TR, Frailty, and Ascites: Therapy Choices?

Presenter: Ronnie Ramadan

June 25, 2025

Presentation NY Valves 2025

Pivot Extend: First-in-Human Application of a Novel Spacer for Treatment of Tricuspid Regurgitation

Presenter: Fabian Barbieri

June 25, 2025

Presentation NY Valves 2025

Case #1: A Patient With Symptomatic Severe TR: Repair or Replace?

Presenter: Jennifer von Stein

June 25, 2025

Presentation NY Valves 2025

Isolated Tricuspid Valve Surgery: Are the Numbers Increasing and the Results Improving?

Presenter: Gorav Ailawadi

June 25, 2025

Presentation NY Valves 2025

TEER Sandwich: Use of a 44mm GORE ASD Occluder to Treat Recurrent Tricuspid Regurgitation After TriClip

Presenter: Mohammed Saad Alkasab

June 25, 2025

Presentation NY Valves 2025

Tricuspid Regurgitation in High Surgical Risk Patient

Presenter: Santiago Andres Castro Vintimilla

June 25, 2025

Presentation NY Valves 2025

Efficacy and Safety of Transcatheter Therapy for Patients With Severe Tricuspid Regurgitation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Presenter: John Cedric Mojica

June 25, 2025

Presentation NY Valves 2025

Advancing Risk Stratification in Tricuspid Regurgitation: Incremental Prognostic Value of Effective RVEF on CMR

Presenter: Edmund Naami

June 25, 2025

News Daily News

‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use

Yael L. Maxwell

June 18, 2025

News Daily News

Valve Thrombosis in TTVR Not Uncommon: Meta-analysis

Caitlin E. Cox

June 17, 2025

News Conference News HRS 2025

Pairing CIED Lead Extraction With Tricuspid Interventions Appears Safe

Todd Neale

April 28, 2025

News Daily News

LuX-Valve TTVR Device Provides Favorable 1-Year Results

Yael L. Maxwell

April 24, 2025

News Daily News

CMS Releases Proposed Decision Memo for Tricuspid TEER

L.A. McKeown

April 04, 2025

News Conference News ACC 2025

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

Michael O'Riordan

March 31, 2025

Presentation ACC 2025

Two-year Outcomes Of Transcatheter Tricuspid Valve Edge-to-Edge Repair For Tricuspid Regurgitation: The TRILUMINATE Pivotal Trial

Presenter: Saibal Kar

March 30, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

News Daily News

CMS Agrees to Reimburse Transcatheter Tricuspid Valve Replacement

Todd Neale

March 20, 2025

News Conference News THT 2025

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

Todd Neale

February 19, 2025

News Daily News

Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit

Yael L. Maxwell

February 12, 2025

Presentation THT Abstracts 2025

TRISCEND II Trial: Right Heart Failure Outcomes in Patients With Severe Tricuspid Regurgitation at One Year

Presenter: Aasim Afzal

February 11, 2025

Advertisement

Case #2: A Patient With Symptomatic Torrential TR, Frailty, and Ascites: Therapy Choices?

Pivot Extend: First-in-Human Application of a Novel Spacer for Treatment of Tricuspid Regurgitation

Case #1: A Patient With Symptomatic Severe TR: Repair or Replace?

Isolated Tricuspid Valve Surgery: Are the Numbers Increasing and the Results Improving?

TEER Sandwich: Use of a 44mm GORE ASD Occluder to Treat Recurrent Tricuspid Regurgitation After TriClip

Tricuspid Regurgitation in High Surgical Risk Patient

Efficacy and Safety of Transcatheter Therapy for Patients With Severe Tricuspid Regurgitation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Advancing Risk Stratification in Tricuspid Regurgitation: Incremental Prognostic Value of Effective RVEF on CMR

‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use

Valve Thrombosis in TTVR Not Uncommon: Meta-analysis

Pairing CIED Lead Extraction With Tricuspid Interventions Appears Safe

LuX-Valve TTVR Device Provides Favorable 1-Year Results

CMS Releases Proposed Decision Memo for Tricuspid TEER

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

Two-year Outcomes Of Transcatheter Tricuspid Valve Edge-to-Edge Repair For Tricuspid Regurgitation: The TRILUMINATE Pivotal Trial

What’s Going to Be Hot at ACC 2025?

CMS Agrees to Reimburse Transcatheter Tricuspid Valve Replacement

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit

TRISCEND II Trial: Right Heart Failure Outcomes in Patients With Severe Tricuspid Regurgitation at One Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content